Computer Programs and Sys... (CPSI)
NASDAQ: CPSI
· Real-Time Price · USD
9.19
0.33 (3.72%)
At close: Mar 01, 2024, 10:00 PM
Computer Programs and Systems Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|
| Acute Care Revenue | 13.14M | 164.23M | 160.84M |
| Acute Care Revenue Growth | -92.00% | +2.11% | n/a |
| Post-Acute Care Revenue | 1.96M | 24.03M | 29.06M |
| Post-Acute Care Revenue Growth | -91.84% | -17.29% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 24.87M | 26.57M | 25.32M | 26.69M | 27.82M | 27.78M | 27.79M | 21.91M | 19.51M | 20.77M | 22.96M | 20.06M | 17.86M | 19.38M | 16.3M | 18.45M | 17.55M | 17.8M | 16.12M | 18.84M | 15.62M | 17.65M | 19.11M | 19.32M | 18.45M | 18.77M | 20.71M | 20.08M | 22.72M | 17.91M | 20.53M | 18.79M | 18.13M | 17.71M | 19.07M | 25.93M | 12.91M | 13.35M | 11.29M | 11.47M |
| Selling, General, and Administrative Revenue Growth | -6.40% | +4.96% | -5.14% | -4.07% | +0.17% | -0.03% | +26.81% | +12.31% | -6.05% | -9.57% | +14.50% | +12.27% | -7.84% | +18.93% | -11.66% | +5.15% | -1.42% | +10.39% | -14.43% | +20.61% | -11.48% | -7.62% | -1.09% | +4.70% | -1.69% | -9.37% | +3.13% | -11.64% | +26.90% | -12.77% | +9.26% | +3.65% | +2.36% | -7.13% | -26.47% | +100.87% | -3.30% | +18.25% | -1.59% | n/a |
| Research and Development Revenue | 8.25M | 4.25M | 7.74M | 8.21M | 10.35M | 9.78M | 10.6M | 9.84M | 8.89M | 7.82M | 7.09M | 7.1M | 7.79M | 7.7M | 6.47M | 8.43M | 8.27M | 8.55M | 8.37M | 8.27M | 9.18M | 9.16M | 9.3M | 9.23M | 8.99M | 9.3M | 9.31M | 8.76M | 10.17M | 9.35M | 9.31M | 8.93M | 8.86M | 8.4M | 8.18M | 7.19M | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | +94.18% | -45.09% | -5.75% | -20.68% | +5.82% | -7.71% | +7.72% | +10.64% | +13.65% | +10.26% | -0.10% | -8.86% | +1.18% | +19.03% | -23.25% | +1.98% | -3.32% | +2.13% | +1.21% | -9.88% | +0.22% | -1.50% | +0.75% | +2.59% | -3.33% | -0.10% | +6.36% | -13.93% | +8.87% | +0.40% | +4.19% | +0.89% | +5.45% | +2.67% | +13.76% | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 5.41M | 5.15M | 5.94M | 7.82M | 6.14M | 6.82M | 8.13M | 6.96M | 4.55M | 7.31M | 8.23M | 7.04M | 6.16M | 5.2M | 5.31M | 5.3M | 5.66M | 6.36M | 5.17M | 7M | 6.61M | 6.65M | 7.02M | 7.49M | 7.93M | 7.55M | 7.52M | 7.71M | 9.76M | 8.53M | 7.61M | 7.13M | 6.85M | 6.89M | 6.72M | 6.73M | 2.91M | 3M | 3.27M | 3.03M |
| Sales and Marketing Revenue Growth | +5.03% | -13.36% | -23.94% | +27.22% | -9.90% | -16.16% | +16.86% | +52.88% | -37.72% | -11.16% | +16.83% | +14.24% | +18.54% | -2.11% | +0.21% | -6.36% | -10.98% | +23.02% | -26.13% | +5.82% | -0.63% | -5.16% | -6.35% | -5.58% | +5.16% | +0.37% | -2.54% | -20.96% | +14.45% | +12.11% | +6.73% | +4.00% | -0.59% | +2.64% | -0.19% | +131.59% | -3.20% | -8.22% | +7.85% | n/a |